Bhuvnesh Aggarwal is a Cardiology physician. OpenAlex indexes 99 publications with 788 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 N 1st St
Springfield, IL 62702
Telephone
217-528-7541Provider last certified this registry record 19 May 2020.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202510 payments
- Novartis Pharmaceuticals CorporationProgram year202523 payments
- PFIZER INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.3%Beta blocker17.8%Metoprolol Succinate63%Metoprolol Tartrate19%Carvedilol11%Atenolol2%Sotalol2%Bisoprolol Fumarate2%Propranolol Hcl Er1%Propranolol Hcl1%Nebivolol Hcl1%Part D<11 patientsStatin13.6%Atorvastatin Calcium56%Rosuvastatin Calcium37%Pravastatin Sodium6%Simvastatin2%Part D<11 patients+ 21 more classes in this area
Blood & clotting
20.1%Factor Xa inhibitor12.8%Eliquis73%Xarelto27%Part D≥221 patientsP2Y12 inhibitor6.5%Clopidogrel79%Brilinta15%Prasugrel Hcl6%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
6.2%SGLT2 inhibitor4%Jardiance85%Farxiga15%Part D≥78 patientsPotassium supplement1.6%Potassium Chloride100%Part D≥50 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention
Methodist DeBakey Cardiovascular Journal
2018 - Utility of Glycated Hemoglobin for Assessment of Glucose Metabolism in Patients With ST-Segment Elevation Myocardial Infarction
The American Journal of Cardiology
2015 - Therapeutic Goals in Patients With Acute Aortic Dissection
Journal of the American College of Cardiology
2015 - Transfer Metrics in Patients With Suspected Acute Aortic Syndrome
Circulation Cardiovascular Quality and Outcomes
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”